The aim of this study was to determine cytosolic estrogen receptor content of the cynomolgus monkey bladder and vagina after hormone replacement therapy. Animals maintained without hormone therapy for 2 years after surgical menopause were randomized to receive either no hormones (OVX), conjugated eq
Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkey
β Scribed by Deirdre Robinson; Robert O. Rainer; Scott A. Washburn; Thomas B. Clarkson
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 480 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0733-2467
No coin nor oath required. For personal study only.
β¦ Synopsis
Menopause is presumed to have a causative role in the development of female urinary incontinence. While some clinical trials have shown that estrogen can affect urinary tract function, our knowledge of the pathophysiologic changes resulting from menopause and hormone replacement therapy is poor.
The cynomolgus monkey is a well-established model for study of menopause and hormone replacement therapy, particularly in the cardiovascular arena. We have utilized this animal model to determine the histologic effects of estrogen and estrogedprogestin replacement therapy in the proximal urethra and vagina.
Estrogen and estrogedprogestin replacement induced an increase in the amount of vaginal but not urethral epithelium. Hormone replacement also resulted in a significant increase in the loose, vascular component of the connective tissue layer of the urethra. The cynomolgus macaque shows promise as a useful model for further study of the effects of hormone replacement on the lower urinary tract. Q 19% Wiley-Liss, Inc.
π SIMILAR VOLUMES
Utilizing a human NK 1 receptor antagonist (RPR 100893), the present in vivo study was designed to test the hypothesis that endogenous substance P (SP) modulates the action of 17β€-estradiol in inducing luteinizing hormone (LH) and follicle stimulating hormone (FSH) surges in ovariectomized cynomolgu